WordNet
- a silvery soft waxy metallic element of the alkali metal group; occurs abundantly in natural compounds (especially in salt water); burns with a yellow flame and reacts violently in water; occurs in sea water and in the mineral halite (rock salt) (同)Na, atomic number 11
PrepTutorEJDIC
- ソジウム,ナトリウム(金属元素;化学記号はNa)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 酸関連疾患治療のためのプロトンポンプ阻害剤の概要および比較 overview and comparison of the proton pump inhibitors for the treatment of acid related disorders
- 2. Antiulcer medications: Mechanism of action, pharmacology, and side effects
- 3. ゾリンジャー - エリソン症候群（ガストリノーマ）のマネージメントおよび予後 management and prognosis of the zollinger ellison syndrome gastrinoma
- 4. Evaluation of the adult with chest pain of esophageal origin
- 5. ヘリコバクターピロリ菌の治療レジメン treatment regimens for helicobacter pylori
English Journal
- The chiral bioconversion and preclinical pharmacokinetic analysis of (R)-(+)-rabeprazole in beagle dogs by HPLC and HPLC-MS/MS.
- Gao YH, Xu JX, Su ZX, Song L, Lou HX.SourceSchool of Pharmaceutical Sciences of Shandong University, No. 44 West Wenhua Road, Jinan, 250012, China.
- Biomedical chromatography : BMC.Biomed Chromatogr.2013 May 22. doi: 10.1002/bmc.2932. [Epub ahead of print]
- In order to accurately investigate the preclinical pharmacokinetics of (R)-(+)-rabeprazole sodium injection, a reliable high-performance liquid chromatography (HPLC) method was developed using a Chiral-AGP column to prove that there is no chiral bioconversion of (R)-(+)-rabeprazole to (S)-(-)-rabepr
- PMID 23703236
- Design and characterization of enteric-coated controlled release mucoadhesive microcapsules of Rabeprazole sodium.
- Swain S, Behera UA, Beg S, Sruti J, Patro ChN, Dinda SC, Rao ME.SourceDepartment of Pharmaceutics, Roland Institute of Pharmaceutical Sciences , Khodasinghi, Berhampur-Gm, Odisha, India. swain_suryakant@yahoo.co.in
- Drug development and industrial pharmacy.Drug Dev Ind Pharm.2013 Apr;39(4):548-60. doi: 10.3109/03639045.2012.676047. Epub 2012 Apr 18.
- The objectives of present work was to design and characterize the rabeprazole sodium loaded microcapsules prepared by solvent evaporation technique using ethyl cellulose (EC) based various mucoadhesive polymer, followed by a triple coating with Eudragit L100. The Box-behnken design (BBD) was applied
- PMID 22512732
- Effect of the residual silanol group protection on the liquid chromatographic resolution of α-amino acids and proton pump inhibitors on a ligand exchange chiral stationary phase.
- Ma DH, Jin JS, Jeong ED, Hyun MH.SourceDepartment of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan, South Korea.
- Journal of separation science.J Sep Sci.2013 Apr;36(8):1349-55. doi: 10.1002/jssc.201300079. Epub 2013 Mar 20.
- A new ligand exchange chiral stationary phase (new CSP) containing residual silanol group-protecting n-octyl groups on the silica surface was prepared by treating a ligand exchange CSP (original CSP) based on sodium N-[(R)-2-hydroxy-1-phenylethyl]-N-undecylaminoacetate bonded to silica gel with exce
- PMID 23420568
Japanese Journal
- ORAL RABEPRAZOLE ADMINISTRATION ON A PROCEDURE DAY SUPPRESSES BLEEDING AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GASTRIC NEOPLASMS
- FUKUSHIMA JOURNAL OF MEDICAL SCIENCE 60(1), 68-74, 2014
- NAID 130004556144
- ジェネリック医薬品の生物学的同等性試験データ情報集 ラベプラゾールナトリウム製剤
- ジェネリック研究 : 日本ジェネリック医薬品学会機関誌 5(1), 137-187, 2011-12
- NAID 40019167898
- 胃内pHからみたラベプラゾールナトリウムの1日2回投与の有用性--難治性GERMこ対するオプションとして (特集 難治性GERDの治療戦略)
- 消化器内科 52(4), 362-369, 2011-04
- NAID 40018857362
Related Links
- Dosage Forms Excipient information presented when available (limited, particularly for generics); consult specific product labeling. Capsule Sprinkle, Oral, as sodium: AcipHex Sprinkle: 5 mg [contains fd&c blue #2 aluminum lake]
- Packaging 10, 50 mg in glass bottle Biochem/physiol Actions Rabeprazole sodium is gastric proton pump inhibitor. It suppresses the production of acid in the stomach by inhibiting the gastric H+/K+ATPase (hydrogen ...
Related Pictures
★リンクテーブル★
| リンク元 | 「ラベプラゾール」 |
「ラベプラゾール」
- 攻撃因子抑制剤
特徴
- 胃酸分泌を速やかに抑制かつ酸分泌回復性に優れガストリン濃度への影響少ない。リバウンドが少ない。
- ガストリン濃度を上げず酸分泌↓→リバウンドが少ない。